Hepatic PI3K deletion prevents steatosis but results in glucose intolerance and impaired AKT activity (Miyake et al. 2002, Taniguchi et al. 2006, Chattopadhyay et al. 2011). This evidence concerns the gene AKT1 and Glucose intolerance.